{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:05:02Z","timestamp":1791875102503,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.intimp.2023.110644","type":"journal-article","created":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T20:56:33Z","timestamp":1689368193000},"page":"110644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis"],"prefix":"10.1016","volume":"122","author":[{"given":"M","family":"Vijaykrishnaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prakash","family":"Patil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeep D","family":"Ghate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adithi K","family":"Bhandary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram M","family":"Haridas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-2637","authenticated-orcid":false,"given":"Praveenkumar","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.intimp.2023.110644_b0005","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/art.41417","article-title":"Rheumatoid arthritis pathogenesis, prediction, and prevention: An emerging paradigm shift","volume":"73","author":"Deane","year":"2021","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0010","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/cei.13256","article-title":"Dendritic cells, T cells and their interaction in rheumatoid arthritis","volume":"196","author":"Wehr","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0015","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41392-023-01331-9","article-title":"Signaling pathways in rheumatoid arthritis: implications for targeted therapy","volume":"8","author":"Ding","year":"2023","journal-title":"Signal Transduct. Target Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0020","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001228","article-title":"Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis","volume":"7","author":"Catrina","year":"2021","journal-title":"RMD Open."},{"issue":"10","key":"10.1016\/j.intimp.2023.110644_b0025","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/art.41385","article-title":"Different hierarchies of anti-modified protein autoantibody reactivities in rheumatoid arthritis","volume":"72","author":"Sahlstrom","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.intimp.2023.110644_b0030","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X21989868","article-title":"The value of anti-CarP and anti-PAD4 as markers of rheumatoid arthritis in ACPA\/RF negative rheumatoid arthritis patients","volume":"13","author":"Kolarz","year":"2021","journal-title":"Ther. Adv. Musculoskelet Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.110644_b0035","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/03009742.2019.1641216","article-title":"Peptidylarginine deiminase 4 (PAD4) activity in early rheumatoid arthritis","volume":"49","author":"Jonsson","year":"2020","journal-title":"Scand J Rheumatol."},{"issue":"7","key":"10.1016\/j.intimp.2023.110644_b0040","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1111\/jth.15313","article-title":"PAD4 takes charge during neutrophil activation: Impact of PAD4 mediated NET formation on immune-mediated disease","volume":"19","author":"Liu","year":"2021","journal-title":"J Thromb Haemost."},{"issue":"178","key":"10.1016\/j.intimp.2023.110644_b0045","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005580","article-title":"NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis","volume":"5","author":"Khandpur","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.intimp.2023.110644_b0050","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.autrev.2017.09.012","article-title":"Neutrophil extracellular traps (NETs) in autoimmune diseases: A comprehensive review","volume":"16","author":"Lee","year":"2017","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.intimp.2023.110644_b0055","doi-asserted-by":"crossref","DOI":"10.3390\/biom9050184","article-title":"Histone deacetylase inhibitors dose-dependently switch neutrophil death from NETosis to apoptosis","volume":"9","author":"Hamam","year":"2019","journal-title":"Biomolecules."},{"issue":"Suppl 3","key":"10.1016\/j.intimp.2023.110644_b0060","doi-asserted-by":"crossref","first-page":"S265","DOI":"10.1186\/ar578","article-title":"Epidemiology and genetics of rheumatoid arthritis","volume":"4","author":"Silman","year":"2002","journal-title":"Arthritis Res."},{"issue":"3","key":"10.1016\/j.intimp.2023.110644_b0065","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jbspin.2018.07.004","article-title":"Methotrexate mechanism in treatment of rheumatoid arthritis","volume":"86","author":"Friedman","year":"2019","journal-title":"Joint Bone Spine."},{"issue":"41","key":"10.1016\/j.intimp.2023.110644_b0070","doi-asserted-by":"crossref","first-page":"e12658","DOI":"10.1097\/MD.0000000000012658","article-title":"Use of steroid and nonsteroidal anti-inflammatories in the treatment of rheumatoid arthritis: Systematic review protocol","volume":"97","author":"Del Grossi","year":"2018","journal-title":"Medicine (Baltimore)."},{"issue":"9","key":"10.1016\/j.intimp.2023.110644_b0075","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1248\/bpb.34.1432","article-title":"Emodin inhibits proinflammatory responses and inactivates histone deacetylase 1 in hypoxic rheumatoid synoviocytes","volume":"34","author":"Ha","year":"2011","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.intimp.2023.110644_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104497","article-title":"Role of biological agents in treatment of rheumatoid arthritis","volume":"150","author":"Law","year":"2019","journal-title":"Pharmacol. Res."},{"issue":"5","key":"10.1016\/j.intimp.2023.110644_b0085","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/annrheumdis-2016-210310","article-title":"Efficacy and safety of sarilumab monotherapy versus adalimumab monotherapy for the treatment of patients with active rheumatoid arthritis (MONARCH): a randomised, double-blind, parallel-group phase III trial","volume":"76","author":"Burmester","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.intimp.2023.110644_b0090","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/rheumatology\/kew056","article-title":"Effect of adalimumab on the work-related outcomes scores in patients with early rheumatoid arthritis receiving methotrexate","volume":"55","author":"Emery","year":"2016","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0095","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/clim.2001.5183","article-title":"Immune function in patients with rheumatoid arthritis treated with etanercept","volume":"103","author":"Moreland","year":"2002","journal-title":"Clin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110644_b0100","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/ard.2011.154211","article-title":"Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay","volume":"71","author":"Grabiec","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"2","key":"10.1016\/j.intimp.2023.110644_b0105","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/art.33382","article-title":"Histone deacetylases are dysregulated in rheumatoid arthritis and a novel histone deacetylase 3-selective inhibitor reduces interleukin-6 production by peripheral blood mononuclear cells from rheumatoid arthritis patients","volume":"64","author":"Gillespie","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.intimp.2023.110644_b0110","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1525-0016(03)00235-1","article-title":"A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis","volume":"8","author":"Chung","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.intimp.2023.110644_b0115","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.biopha.2018.02.030","article-title":"MicroRNA signature of regulatory T cells in health and autoimmunity","volume":"100","author":"Soltanzadeh-Yamchi","year":"2018","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.intimp.2023.110644_b0120","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/gene.2011.45","article-title":"DNA methylation regulates the expression of CXCL12 in rheumatoid arthritis synovial fibroblasts","volume":"12","author":"Karouzakis","year":"2011","journal-title":"Genes Immun."},{"issue":"10","key":"10.1016\/j.intimp.2023.110644_b0125","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.4049\/jimmunol.1400066","article-title":"Epigenome analysis reveals TBX5 as a novel transcription factor involved in the activation of rheumatoid arthritis synovial fibroblasts","volume":"193","author":"Karouzakis","year":"2014","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0130","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/annrheumdis-2012-201526","article-title":"DNA methylome signature in rheumatoid arthritis","volume":"72","author":"Nakano","year":"2013","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.intimp.2023.110644_b0135","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1073\/pnas.0608773104","article-title":"Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts","volume":"104","author":"Meinecke","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U S A."},{"issue":"2","key":"10.1016\/j.intimp.2023.110644_b0140","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3892\/mmr.2015.3642","article-title":"Downregulation of microRNA-221 decreases migration and invasion in fibroblast-like synoviocytes in rheumatoid arthritis","volume":"12","author":"Yang","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.110644_b0145","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imcb.12311","article-title":"Epigenetics in rheumatoid arthritis; fibroblast-like synoviocytes as an emerging paradigm in the pathogenesis of the disease","volume":"98","author":"Karami","year":"2020","journal-title":"Immunol. Cell Biol."},{"issue":"9","key":"10.1016\/j.intimp.2023.110644_b0150","doi-asserted-by":"crossref","DOI":"10.3390\/cells8090953","article-title":"DNA methylation as a future therapeutic and diagnostic target in rheumatoid arthritis","volume":"8","author":"Ciechomska","year":"2019","journal-title":"Cells"},{"issue":"5","key":"10.1016\/j.intimp.2023.110644_b0155","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s10753-017-0591-8","article-title":"MeCP2 regulates PTCH1 expression through DNA methylation in rheumatoid arthritis","volume":"40","author":"Sun","year":"2017","journal-title":"Inflammation"},{"issue":"3","key":"10.1016\/j.intimp.2023.110644_b0160","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.39952","article-title":"Rheumatoid arthritis naive T cells share hypermethylation sites with synoviocytes","volume":"69","author":"Rhead","year":"2017","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110644_b0165","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/art.40408","article-title":"Hypomethylation of CYP2E1 and DUSP22 promoters associated with disease activity and erosive disease among rheumatoid arthritis patients","volume":"70","author":"Mok","year":"2018","journal-title":"Arthritis Rheumatol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110644_b0170","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.18632\/oncotarget.22918","article-title":"Comprehensive analysis of gene expression and DNA methylation datasets identify valuable biomarkers for rheumatoid arthritis progression","volume":"9","author":"Fang","year":"2018","journal-title":"Oncotarget."},{"key":"10.1016\/j.intimp.2023.110644_b0175","doi-asserted-by":"crossref","first-page":"510","DOI":"10.3389\/fimmu.2016.00510","article-title":"Differentially methylated DNA regions in monozygotic twin pairs discordant for rheumatoid arthritis: An epigenome-wide study","volume":"7","author":"Svendsen","year":"2016","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0180","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s13075-015-0748-5","article-title":"Assessment of global DNA methylation in peripheral blood cell subpopulations of early rheumatoid arthritis before and after methotrexate","volume":"17","author":"de Andres","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.110644_b0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102438","article-title":"Clinical significance of miRNAs in autoimmunity","volume":"109","author":"Zhang","year":"2020","journal-title":"J. Autoimmun."},{"issue":"3","key":"10.1016\/j.intimp.2023.110644_b0190","doi-asserted-by":"crossref","DOI":"10.3390\/cells11030452","article-title":"miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis","volume":"11","author":"Kmiolek","year":"2022","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.intimp.2023.110644_b0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11926-016-0604-x","article-title":"The role of microRNAs and their targets in osteoarthritis","volume":"18","author":"Sondag","year":"2016","journal-title":"Curr. Rheumatol. Rep."},{"issue":"3","key":"10.1016\/j.intimp.2023.110644_b0200","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1038\/icb.2011.114","article-title":"Novel regulatory mechanisms in inflammatory arthritis: a role for microRNA","volume":"90","author":"Baxter","year":"2012","journal-title":"Immunol. Cell Biol."},{"issue":"4","key":"10.1016\/j.intimp.2023.110644_b0205","first-page":"586","article-title":"Detecting novel micro RNAs in rheumatoid arthritis with gene-based association testing","volume":"35","author":"Lenert","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0210","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1186\/s13075-017-1459-x","article-title":"Whole blood microRNA expression pattern differentiates patients with rheumatoid arthritis, their seropositive first-degree relatives, and healthy unrelated control subjects","volume":"19","author":"Anaparti","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.intimp.2023.110644_b0215","doi-asserted-by":"crossref","first-page":"5292","DOI":"10.12659\/MSM.908219","article-title":"miR-145-5p increases osteoclast numbers in vitro and aggravates bone erosion in collagen-induced arthritis by targeting osteoprotegerin","volume":"24","author":"Chen","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.intimp.2023.110644_b0220","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2017.01.002","article-title":"MicroRNA-155 contributes to enhanced resistance to apoptosis in monocytes from patients with rheumatoid arthritis","volume":"79","author":"Rajasekhar","year":"2017","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0225","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10238-018-0524-3","article-title":"Upregulation of miR-221\/222 expression in rheumatoid arthritis (RA) patients: correlation with disease activity","volume":"19","author":"Abo ElAtta","year":"2019","journal-title":"Clin. Exp. Med."},{"issue":"2","key":"10.1016\/j.intimp.2023.110644_b0230","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10753-016-0304-8","article-title":"Correlation between the expression of microRNA-301a-3p and the proportion of Th17 cells in patients with rheumatoid arthritis","volume":"39","author":"Tang","year":"2016","journal-title":"Inflammation"},{"issue":"2","key":"10.1016\/j.intimp.2023.110644_b0235","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/jcb.26659","article-title":"MiR-548a-3p regulates inflammatory response via TLR4\/NF-kappaB signaling pathway in rheumatoid arthritis","volume":"120","author":"Wang","year":"2019","journal-title":"J. Cell Biochem."},{"issue":"6","key":"10.1016\/j.intimp.2023.110644_b0240","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1080\/13813455.2020.1773862","article-title":"MiRNA-6089 inhibits rheumatoid arthritis fibroblast-like synoviocytes proliferation and induces apoptosis by targeting CCR4","volume":"128","author":"Lin","year":"2022","journal-title":"Arch. Physiol. Biochem."},{"issue":"8","key":"10.1016\/j.intimp.2023.110644_b0245","doi-asserted-by":"crossref","first-page":"e363","DOI":"10.1038\/emm.2017.108","article-title":"MicroRNA-143 and -145 modulate the phenotype of synovial fibroblasts in rheumatoid arthritis","volume":"49","author":"Hong","year":"2017","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0250","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1186\/s13104-017-2715-5","article-title":"TNF-alpha-induced miR-155 regulates IL-6 signaling in rheumatoid synovial fibroblasts","volume":"10","author":"Migita","year":"2017","journal-title":"BMC Res. Notes."},{"issue":"45","key":"10.1016\/j.intimp.2023.110644_b0255","doi-asserted-by":"crossref","first-page":"74217","DOI":"10.18632\/oncotarget.12487","article-title":"MicroRNA-126 affects rheumatoid arthritis synovial fibroblast proliferation and apoptosis by targeting PIK3R2 and regulating PI3K-AKT signal pathway","volume":"7","author":"Qu","year":"2016","journal-title":"Oncotarget."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0260","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13075-017-1465-z","article-title":"The role of aberrant expression of T cell miRNAs affected by TNF-alpha in the immunopathogenesis of rheumatoid arthritis","volume":"19","author":"Lai","year":"2017","journal-title":"Arthritis Res. Ther."},{"issue":"7","key":"10.1016\/j.intimp.2023.110644_b0265","doi-asserted-by":"crossref","first-page":"7960","DOI":"10.21037\/apm-21-1383","article-title":"MicroRNA-449 targets histone deacetylase 1 to regulate the proliferation, invasion, and apoptosis of synovial fibroblasts in rheumatoid arthritis","volume":"10","author":"Guo","year":"2021","journal-title":"Ann. Palliat. Med."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0270","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.bbrc.2019.08.092","article-title":"miR-138 activates NF-kappaB signaling and PGRN to promote rheumatoid arthritis via regulating HDAC4","volume":"519","author":"Shao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"7","key":"10.1016\/j.intimp.2023.110644_b0275","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1136\/ard.2005.044065","article-title":"Trichostatin A sensitises rheumatoid arthritis synovial fibroblasts for TRAIL-induced apoptosis","volume":"65","author":"Jungel","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.intimp.2023.110644_b0280","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.4049\/jimmunol.0901467","article-title":"Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue","volume":"184","author":"Grabiec","year":"2010","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.intimp.2023.110644_b0285","doi-asserted-by":"crossref","first-page":"e70939","DOI":"10.1371\/journal.pone.0070939","article-title":"Imbalance between HAT and HDAC activities in the PBMCs of patients with ankylosing spondylitis or rheumatoid arthritis and influence of HDAC inhibitors on TNF alpha production","volume":"8","author":"Toussirot","year":"2013","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0290","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13075-020-02258-0","article-title":"Therapeutic potential of CKD-506, a novel selective histone deacetylase 6 inhibitor, in a murine model of rheumatoid arthritis","volume":"22","author":"Park","year":"2020","journal-title":"Arthritis. Res. Ther."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0295","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s13075-021-02561-4","article-title":"Inhibition of histone deacetylase 6 suppresses inflammatory responses and invasiveness of fibroblast-like-synoviocytes in inflammatory arthritis","volume":"23","author":"Park","year":"2021","journal-title":"Arthritis. Res. Ther."},{"issue":"4","key":"10.1016\/j.intimp.2023.110644_b0300","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/s10753-013-9616-0","article-title":"Therapeutic effects of NK-HDAC-1, a novel histone deacetylase inhibitor, on collagen-induced arthritis through the induction of apoptosis of fibroblast-like synoviocytes","volume":"36","author":"Li","year":"2013","journal-title":"Inflammation"},{"issue":"9","key":"10.1016\/j.intimp.2023.110644_b0305","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1093\/rheumatology\/kev022","article-title":"Inhibiting histone deacetylase 1 suppresses both inflammation and bone loss in arthritis","volume":"54","author":"Cantley","year":"2015","journal-title":"Rheumatology"},{"issue":"10","key":"10.1016\/j.intimp.2023.110644_b0310","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1002\/art.20709","article-title":"Histone deacetylase inhibitor suppression of autoantibody-mediated arthritis in mice via regulation of p16INK4a and p21(WAF1\/Cip1) expression","volume":"50","author":"Nishida","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"8","key":"10.1016\/j.intimp.2023.110644_b0315","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/acs.jmedchem.7b01593","article-title":"Marbostat-100 defines a new class of potent and selective antiinflammatory and antirheumatic histone deacetylase 6 inhibitors","volume":"61","author":"Sellmer","year":"2018","journal-title":"J Med Chem."},{"key":"10.1016\/j.intimp.2023.110644_b0320","first-page":"8","article-title":"CKD-506, a novel HDAC6-selective inhibitor, improves renal outcomes and survival in a mouse model of systemic lupus erythematosus","author":"Choi","year":"2018","journal-title":"Sci. Rep.-Uk."},{"key":"10.1016\/j.intimp.2023.110644_b0325","doi-asserted-by":"crossref","first-page":"5648987","DOI":"10.1155\/2019\/5648987","article-title":"Suberoylanilide hydroxamic acid attenuates autoimmune arthritis by suppressing Th17 cells through NR1D1 inhibition","volume":"2019","author":"Kim","year":"2019","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2023.110644_b0330","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3389\/fimmu.2018.01525","article-title":"Attenuation of rheumatoid inflammation by sodium butyrate through reciprocal targeting of HDAC2 in osteoclasts and HDAC8 in T cells","volume":"9","author":"Kim","year":"2018","journal-title":"Front Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2023.110644_b0335","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.intimp.2013.03.016","article-title":"Tubastatin, a selective histone deacetylase 6 inhibitor shows anti-inflammatory and anti-rheumatic effects","volume":"16","author":"Vishwakarma","year":"2013","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"10.1016\/j.intimp.2023.110644_b0340","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.yexmp.2009.06.003","article-title":"Deacetylase inhibition increases regulatory T cell function and decreases incidence and severity of collagen-induced arthritis","volume":"87","author":"Saouaf","year":"2009","journal-title":"Exp. Mol. Pathol."},{"issue":"6","key":"10.1016\/j.intimp.2023.110644_b0345","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.joca.2007.10.014","article-title":"Trichostatin A, a histone deacetylase inhibitor, suppresses synovial inflammation and subsequent cartilage destruction in a collagen antibody-induced arthritis mouse model","volume":"16","author":"Nasu","year":"2008","journal-title":"Osteoarthritis Cartil."},{"issue":"7","key":"10.1016\/j.intimp.2023.110644_b0350","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/sj.bjp.0707165","article-title":"Anti-rheumatic activities of histone deacetylase (HDAC) inhibitors in vivo in collagen-induced arthritis in rodents","volume":"150","author":"Lin","year":"2007","journal-title":"Br. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.intimp.2023.110644_b0355","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s10875-011-9508-8","article-title":"Trichostatin differentially regulates Th1 and Th2 responses and alleviates rheumatoid arthritis in mice","volume":"31","author":"Zhou","year":"2011","journal-title":"J. Clin. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576923009694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:26:38Z","timestamp":1736432798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576923009694"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":71,"alternative-id":["S1567576923009694"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110644","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of HDAC inhibitors and epigenetic modulation in the amelioration of synovial inflammation, cellular invasion, and bone erosion in rheumatoid arthritis pathogenesis","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2023.110644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110644"}}